Keywords: pharmamar, reports, progress, yondelis, soft, tissue, sarcoma

PharmaMar reports progress for Yondelis in soft tissue sarcoma

Article | 09 January 2006

Print This

Spain's PharmaMar says that the independent data monitoring committee for the pivotal trial of Yondelis (trabectedin) in soft tissue sarcoma ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in